Add like
Add dislike
Add to saved papers

Biofilm production ability of Streptococcus dysgalactiae subsp. equisimilis: relatedness with host, Lancefield group, source, clonal complex, and virulence-associated gene.

We assessed biofilm production ability (BPA) of noninvasive Streptococcus dysgalactiae subsp. equisimilis (SDSE) from humans/companion animals and determined relationships between BPA populations and other host/microbiological features. Sixty-four companion animal-/human-origin isolates were collected with host information. We measured BPA using crystal violet staining, along with doing emm typing, multilocus sequence typing, and antimicrobial resistance (AMR) phenotyping/genotyping, and detection of virulence-associated genes (VAGs) (prtF1-prtF2-lmb-cbp-sicG-srtp1-srtp2-brpA). Significant difference in BPA of SDSE from different hosts/sources and with different Lancefield groups was assessed. We analyzed associations between BPA populations (strong/moderate/weak/no biofilm producers) and emm types, sequence types/clonal complexes (CCs), AMR phenotypes/genotypes, and VAG types. Seventeen, twenty-four, and twelve isolates belonged to strong, moderate, and weak biofilm producers: eleven showed no BPA. There was a difference in BPA distributions between human- and animal-origins and between groups G and C isolates. We found an association of BPA populations with eye/ear source (vs. pus/skin source). There was a relationship between BPA populations and CC127 (vs. CC17). We observed no associations of BPA populations with AMR phenotype/genotype. There was an association of BPA distributions with srtp1 detection. Our observations suggest potential associations of BPA with host, Lancefield group, source, CC, or VAG.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app